STOCKSFifteen Fabulously Intelligent Biotech Stock Predictions for 2015By Adam FeuersteinJan 6, 2015 11:52 AM EST
STOCKSBiotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter LensBy Adam FeuersteinDec 29, 2014 6:00 AM EST
INVESTINGWhere Are They Now? A Look Back at the Best & Worst Biotech CEOsBy Adam FeuersteinDec 16, 2014 11:20 AM EST
STOCKSNominees for Absolute Worst Biotechnology CEOs of 2014 Are ...By Adam FeuersteinDec 15, 2014 11:49 AM EST
STOCKSUsing Re-Engineered Immune Cells to Kill Leukemia Induces Lasting RemissionsBy Adam FeuersteinDec 6, 2014 1:00 PM EST
MARKETSStock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba SpikesBy Keris Alison LahiffNov 10, 2014 3:02 PM EST
MARKETSStock Market Today: Wall Street Is Static With Little News to Move MarketsBy Keris Alison LahiffNov 10, 2014 10:44 AM EST
MARKETSStock Market Today: Futures Rise Slightly as Stocks Set Up for Further RecordsBy Keris Alison LahiffNov 10, 2014 8:31 AM EST
STOCKSThe Next Chapter in Dendreon's Troubled History: Chapter 11 BankruptcyBy Adam FeuersteinNov 10, 2014 7:12 AM EST
STOCKSNovember 10 Premarket Briefing: 10 Things You Should KnowBy Joseph WoelfelNov 10, 2014 6:54 AM EST
MARKETSStock Market Story: Stocks Finish Flat as Markets ConsolidateBy Andrea TseAug 12, 2014 4:17 PM EDT
MARKETSStock Market Story: U.S. Stocks Hit Intraday Lows After Running Up Too Far, Too FastBy Andrea TseAug 12, 2014 12:33 PM EDT
INVESTINGDendreon Warns Debt Bomb Might Wipe Out ShareholdersBy Adam FeuersteinAug 12, 2014 7:17 AM EDT
MARKETSJim Cramer Talks Dendreon (DNDN), Salesforce.com (CRM) and Yelp (YELP)By Andrew MeolaJun 9, 2014 12:18 PM EDT
MARKETSTrade-Ideas: Dendreon (DNDN) Is Today's "Perilous Reversal" StockBy Scott OlsonMar 4, 2014 9:48 AM EST
MARKETSTrade-Ideas: Dendreon (DNDN) Is Today's Pre-Market Mover With Heavy Volume StockBy Jamie HodgeMar 3, 2014 8:57 AM EST
